Administration of tetrahydrobiopterin improves the microcirculation and outcome in an ovine model of septic shock

Critical Care Medicine

Volumn 40, Issue 10, 2012, Pages 2833-2840

  He, Xinrong ^a   Su, Fuhong ^a   Velissaris, Dimitrios ^a   Salgado, Diamantino Ribeiro ^a   Barros, Dalton De Souza ^a   Lorent, Sophie ^a   Taccone, Fabio Silvio ^a   Vincent, Jean Louis ^a   De Backer, Daniel ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

hemodynamics; microcirculation; pulmonary gas exchange; septic shock; tetrahydrobiopterin

Indexed keywords

LACTIC ACID; PLACEBO; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DRUG EFFECT; DRY WEIGHT; FEMALE; FLUID RESUSCITATION; HEART HEMODYNAMICS; HEART INDEX; HEART RATE; KIDNEY BLOOD FLOW; LACTATE BLOOD LEVEL; LUNG COMPLIANCE; LUNG GAS EXCHANGE; LUNG PERFUSION; MEAN ARTERIAL PRESSURE; MECONIUM PERITONITIS; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SHEEP; SURVIVAL TIME; TREATMENT OUTCOME; URINE VOLUME; VENOUS OXYGEN TENSION; VIDEO MICROSCOPY;

ANIMALS; BIOPTERIN; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMICS; MICROCIRCULATION; PERITONITIS; PULMONARY GAS EXCHANGE; RANDOM ALLOCATION; SHEEP; SHOCK, SEPTIC;

EID: 84866562435     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31825b88ba     Document Type: Article

References (54)

1. De Backer D, Creteur J, Preiser JC, et al: Microvascular blood fow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166:98-104 (Pubitemid 34693970)
2. Trzeciak S, Rivers EP: Clinical manifestations of disordered microcirculatory perfu-sion in severe sepsis. Crit Care 2005; 9(Suppl 4):S20-S26 (Pubitemid 41498528)
3. Sakr Y, Dubois MJ, De Backer D, et al: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825-1831 (Pubitemid 39202356)
4. Top AP, Ince C, Schouwenberg PH, et al: Inhaled nitric oxide improves systemic microcirculation in infants with hypoxemic respiratory failure. Pediatr Crit Care Med 2011; 12:e271-e274
5. Creteur J, Carollo T, Soldati G, et al: The prognostic value of muscle StO2 in septic patients. Intensive Care Med 2007; 33:1549-1556 (Pubitemid 47312484)
6. Doerschug KC, Delsing AS, Schmidt GA, et al: Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol 2007; 293:H1065-H1071 (Pubitemid 47254206)
7. Ospina-Tascon G, Neves AP, Occhipinti G, et al: Effects of fuids on microvascular perfu-sion in patients with severe sepsis. Intensive Care Med 2010; 36:949-955
8. De Backer D, Creteur J, Dubois MJ, et al: The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006; 34:403-408 (Pubitemid 43145619)
9. De Backer D, Verdant C, Chierego M, et al: Effects of drotrecogin alfa activated on micro-circulatory alterations in patients with severe sepsis. Crit Care Med 2006; 34:1918-1924 (Pubitemid 43982468)
10. Ince C: Microcirculation in distress: A new resuscitation end point? Crit Care Med 2004; 32:1963-1964 (Pubitemid 39202377)
11. Li JM, Shah AM: Endothelial cell superox-ide generation: Regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004; 287:R1014-R1030 (Pubitemid 39391043)
12. Huet O, Dupic L, Harrois A, et al: Oxidative stress and endothelial dysfunction during sepsis. Front Biosci 2011; 16:1986-1995
13. Ait-Oufella H, Maury E, Lehoux S, et al: The endothelium: Physiological functions and role in microcirculatory failure during severe sepsis. Intensive Care Med 2010; 36:1286-1298
14. Lee WL, Liles WC: Endothelial activation, dysfunction and permeability during severe infections. Curr Opin Hematol 2011; 18:191-196
15. Schmidt TS, Alp NJ: Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci 2007; 113:47-63 (Pubitemid 47066025)
16. Pou S, Pou WS, Bredt DS, et al: Generation of superoxide by purifed brain nitric oxide syn-thase. J Biol Chem 1992; 267:24173-24176
17. Kim HL, Park YS: Maintenance of cellular tetrahydrobiopterin homeostasis. BMB Rep 2010; 43:584-592
18. Cosentino F, Lüscher TF: Tetrahydrobiop-terin and endothelial nitric oxide synthase activity. Cardiovasc Res 1999; 43:274-278 (Pubitemid 29356362)
19. Maglione M, Hermann M, Hengster P, et al: Tetrahydrobiopterin attenuates microvascu-lar reperfusion injury following murine pancreas transplantation. Am J Transplant 2006; 6:1551-1559 (Pubitemid 43945795)
20. Wang WZ, Fang XH, Stephenson LL, et al: Effects of supplementation of BH4 after prolonged ischemia in skeletal muscle. Microsurgery 2007; 27:200-205 (Pubitemid 46608882)
21. Setoguchi S, Mohri M, Shimokawa H, et al: Tetrahydrobiopterin improves endothelial dysfunction in coronary microcirculation in patients without epicardial coronary artery disease. J Am Coll Cardiol 2001; 38:493-498 (Pubitemid 32721779)
22. Ihlemann N, Rask-Madsen C, Perner A, et al: Tetrahydrobiopterin restores endothe-lial dysfunction induced by an oral glucose challenge in healthy subjects. Am J Physiol Heart Circ Physiol 2003; 285:H875-H882 (Pubitemid 36885922)
23. Secor D, Li F, Ellis CG, et al: Impaired micro-vascular perfusion in sepsis requires activated coagulation and P-selectin-mediated platelet adhesion in capillaries. Intensive Care Med 2010; 36:1928-1934
24. Tyml K, Li F, Wilson JX: Septic impairment of capillary blood fow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism. Crit Care Med 2008; 36:2355-2362
25. Fitzal F, Redl H, Strohmaier W, et al: A 4-amino analogue of tetrahydrobiopterin attenuates endotoxin-induced hemodynamic alterations and organ injury in rats. Shock 2002; 18:158-162
26. Bahrami S, Fitzal F, Peichl G, et al: Protection against endotoxemia in rats by a novel tetrahydrobiopterin analogue. Shock 2000; 13:386-391
27. Patel A, Rhodes A, Beale R: Assessment of cardiac flling and blood fow. In: Critical Care Medicine: Principles of Diagnosis and Management in the Adult. Third Edition. Parrillo JE, Dellinger RP (Eds). Philadelphia, Mosby Elsevier, 2007, pp 39-52
28. Souba WW, Wilmore DW: Surgical Research. Sand Diego, Academic Press, 2001
29. De Backer D, Hollenberg S, Boerma C, et al: How to evaluate the microcirculation: Report of a round table conference. Crit Care 2007; 11:R101
30. Su F, Huang H, Akieda K, et al: Effects of a selective iNOS inhibitor versus norepineph-rine in the treatment of septic shock. Shock 2010; 34:243-249
31. Spronk PE, Zandstra DF, Ince C: Bench-to-bedside review: Sepsis is a disease of the microcirculation. Crit Care 2004; 8:462-468 (Pubitemid 40073681)
32. Trzeciak S, McCoy JV, Phillip Dellinger R, et al; Microcirculatory Alterations in Resuscitation and Shock (MARS) investigators: Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008; 34:2210-2217
33. Mittermayer F, Pleiner J, Schaller G, et al: Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005; 289:H1752-H1757 (Pubitemid 41369021)
34. Boueiz A, Hassoun PM: Regulation of endo-thelial barrier function by reactive oxygen and nitrogen species. Microvasc Res 2009; 77:26-34
35. Huet O, Obata R, Aubron C, et al: Plasma-induced endothelial oxidative stress is related to the severity of septic shock. Crit Care Med 2007; 35:821-826 (Pubitemid 46407797)
36. Lirk P, Hoffmann G, Rieder J: Inducible nitric oxide synthase-time for reappraisal. Curr Drug Targets Infamm Allergy 2002; 1:89-108
37. Kuzkaya N, Weissmann N, Harrison DG, et al: Interactions of peroxynitrite, tetrahydrobiop-terin, ascorbic acid, and thiols: Implications for uncoupling endothelial nitric-oxide syn-thase. J Biol Chem 2003; 278:22546-22554 (Pubitemid 36830310)
38. Bendall JK, Alp NJ, Warrick N, et al: Stoi-chiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: Insights from transgenic mice with endothe-lial-targeted GTP cyclohydrolase 1 and eNOS overexpression. Circ Res 2005; 97:864-871 (Pubitemid 41552671)
39. Sun J, Druhan LJ, Zweier JL: Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production. Arch Biochem Biophys 2010; 494:130-137
40. Enkhbaatar P, Murakami K, Traber LD, et al: The inhibition of inducible nitric oxide synthase in ovine sepsis model. Shock 2006; 25:522-527
41. Lange M, Connelly R, Traber DL, et al: Time course of nitric oxide synthases, nitrosative stress, and poly(ADP ribosylation) in an ovine sepsis model. Crit Care 2010; 14:R129
42. Matejovic M, Krouzecky A, Radej J, et al: Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bactere-mia-effects of selective inducible nitric oxide synthase inhibition. Thromb Haemost 2007; 97:304-309 (Pubitemid 46592152)
43. Hatakeyama T, Pappas PJ, Hobson RW 2nd, et al: Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo. J Physiol (Lond) 2006; 574(Pt 1):275-281 (Pubitemid 43905811)
44. Xia N, Daiber A, Habermeier A, et al: Res-veratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther 2010; 335:149-154
45. Förstermann U, Li H: Therapeutic effect of enhancing endothelial nitric oxide syn-thase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol 2011; 164:213-223
46. Francis BN, Wilkins MR, Zhao L: Tetrahydro-biopterin and the regulation of hypoxic pulmonary vasoconstriction. Eur Respir J 2010; 36:323-330
47. Ward PA: Oxidative stress: Acute and progressive lung injury. Ann N Y Acad Sci 2010; 1203:53-59
48. Lange M, Nakano Y, Traber DL, et al: Role of different nitric oxide synthase isoforms in a murine model of acute lung injury and sepsis. Biochem Biophys Res Commun 2010; 399:286-291
49. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004; 351:159-169
50. Mitaka C, Hirata Y, Yokoyama K, et al: A selective inhibitor for inducible nitric oxide synthase improves hypotension and lactic acidosis in canine endotoxic shock. Crit Care Med 2001; 29:2156-2161 (Pubitemid 33063545)
51. Su F, Brands R, Wang Z, et al: Benefcial effects of alkaline phosphatase in septic shock. Crit Care Med 2006; 34:2182-2187 (Pubitemid 44305623)
52. Miller L, Insel T, Scheinin M, et al: Tetra-hydrobiopterin administration to rhesus macaques. Its appearance in CSF and effect on neurotransmitter synthesis. Neurochem Res 1986; 11:291-298 (Pubitemid 16161268)
53. Schmid RA, Hillinger S, Walter R, et al: The nitric oxide synthase cofactor tetrahydrobiop-terin reduces allograft ischemia-reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 1999; 118:726-732 (Pubitemid 29474800)
54. Verdant CL, De Backer D, Bruhn A, et al: Evaluation of sublingual and gut mucosal microcirculation in sepsis: A quantitative analysis. Crit Care Med 2009; 37:2875-2881